We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+11.07%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.1B
AUM Growth
-$1.95B
Cap. Flow
-$2.01B
Cap. Flow %
-182.11%
Top 10 Hldgs %
55.43%
Holding
359
New
34
Increased
188
Reduced
93
Closed
36

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$38.7M
2
SE icon
Sea Limited
SE
+$29.1M
3
MELI icon
Mercado Libre
MELI
+$27M
4
META icon
Meta Platforms (Facebook)
META
+$19.3M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$17.2M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.32B
2
JD icon
JD.com
JD
+$301M
3
BIDU icon
Baidu
BIDU
+$279M
4
NTES icon
NetEase
NTES
+$202M
5
TCOM icon
Trip.com Group
TCOM
+$77.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 35.58%
2 Technology 17.59%
3 Communication Services 16.9%
4 Healthcare 11.23%
5 Real Estate 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HD icon
126
Home Depot
HD
$332B
$563K 0.05%
2,052
-7
-0.3% -$2.07K
MRK icon
127
Merck
MRK
$307B
$561K 0.05%
6,156
-145
-2% -$12.9K
NVAX icon
128
Novavax
NVAX
$1.3B
$554K 0.05%
10,780
+7,104
+193% +$368K
FATE icon
129
Fate Therapeutics
FATE
$325M
$548K 0.05%
22,103
+14,107
+176% +$389K
KRTX
130
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$546K 0.05%
4,316
+1,709
+66% +$196K
PTCT icon
131
PTC Therapeutics
PTCT
$6.47B
$543K 0.05%
13,553
+5,723
+73% +$201K
MNST icon
132
Monster Beverage
MNST
$93.4B
$538K 0.05%
11,610
+112
+1% +$4.87K
NTLA icon
133
Intellia Therapeutics
NTLA
$1.53B
$534K 0.05%
10,315
+5,938
+136% +$302K
KDP icon
134
Keurig Dr Pepper
KDP
$41.4B
$531K 0.05%
15,011
+1,782
+13% +$64.7K
TMO icon
135
Thermo Fisher Scientific
TMO
$196B
$525K 0.05%
966
-6
-0.6% -$3.3K
RARE icon
136
Ultragenyx Pharmaceutical
RARE
$2.81B
$524K 0.05%
8,779
+4,678
+114% +$288K
BEAM icon
137
Beam Therapeutics
BEAM
$2.71B
$512K 0.05%
13,237
+8,833
+201% +$351K
EXC icon
138
Exelon
EXC
$47B
$512K 0.05%
11,307
+141
+1% +$6.63K
ARWR icon
139
Arrowhead Research
ARWR
$10.1B
$505K 0.05%
14,347
+7,926
+123% +$298K
EXEL icon
140
Exelixis
EXEL
$14B
$503K 0.05%
24,138
+11,358
+89% +$234K
KHC icon
141
Kraft Heinz
KHC
$30.7B
$499K 0.05%
13,088
+24
+0.2% +$961
MRTX
142
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$498K 0.05%
7,413
+4,092
+123% +$260K
SWTX
143
DELISTED
SpringWorks Therapeutics
SWTX
$493K 0.04%
20,031
+15,474
+340% +$566K
KO icon
144
Coca-Cola
KO
$353B
$487K 0.04%
7,747
+164
+2% +$10.4K
ALNY icon
145
Alnylam Pharmaceuticals
ALNY
$36.4B
$483K 0.04%
3,315
+1,583
+91% +$225K
BMRN icon
146
BioMarin Pharmaceuticals
BMRN
$11.4B
$483K 0.04%
5,832
+2,301
+65% +$183K
APLS
147
DELISTED
Apellis Pharmaceuticals
APLS
$482K 0.04%
10,651
+4,455
+72% +$203K
VIR icon
148
Vir Biotechnology
VIR
$1.56B
$482K 0.04%
18,939
+6,656
+54% +$155K
ORLY icon
149
O'Reilly Automotive
ORLY
$70.1B
$480K 0.04%
11,400
-90
-0.8% -$3.87K
ABT icon
150
Abbott
ABT
$177B
$476K 0.04%
4,385
-8
-0.2% -$909
4 5
6
7 8

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q2 2022 Portfolio in Review

As of Q2 2022, E Fund Management held 359 positions worth $1.1B, down 64% from $3.06B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

E Fund Management withdrew a net $2.01B in Q2 2022, closing 36 positions and reducing 93 holdings. Its most notable exit was Alibaba, an estimated $1.32B position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 63% a quarter earlier, followed by Technology and Communication Services.

Against the trend, E Fund Management opened a new position in Sea Limited worth $22.9M.

  • E Fund Management's largest Q2 2022 buy was Sea Limited: 342,000 shares worth $22.9M.
  • E Fund Management added most to STAAR Surgical in Q2 2022, an estimated $38.7M increase.
  • E Fund Management's biggest Q2 2022 reduction was JD.com, cutting an estimated $301M.
  • E Fund Management fully exited Alibaba in Q2 2022, selling an estimated $1.32B.
  • E Fund Management's ten largest holdings make up 55% of its $1.1B portfolio in Q2 2022.
  • E Fund Management opened 34 new positions and closed 36 in Q2 2022.
  • E Fund Management's portfolio value fell 64% quarter-over-quarter to $1.1B.

Based on E Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.